viewTilray Inc

Tilray quarterly revenue shoots up 95% but net loss at US$12.8mln; stock jumps 22% to 52-week top

The company said it is "well-positioned to continue to pioneer the development of the global medical cannabis market and to become a leader in the adult-use cannabis market in Canada,"

Tilray Inc is a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor based in British Columbia.

Tilray Inc (NASDAQ:TLRY). had quite the bumper crop day as it reported its quarterly earnings, sparking a robust rally in its shares on Wednesday. 

Revenue was up to US$9.7mln (C$12.7mln), up an eye-popping 95.2% compared to the second quarter of last year. The increase in revenue was driven by increased patient demand in Canada, sales to other licensed producers and international sales.

“We are very pleased with our strong start to 2018. Tilray is well-positioned to continue to pioneer the development of the global medical cannabis market and to become a leader in the adult-use cannabis market in Canada,” said Brendan Kennedy, president and chief executive officer of Tilray.

“In the second quarter, we generated significant revenue growth as a result of our global strategy, our multinational distribution network and our commitment to research, innovation, quality and operational excellence.”

The market reacted strongly on Wednesday, as Tilray's stock in New York jumped up more than 22% to hit a 52-week high of US$62.75. It was trading midday up 21% at US$62.33.

READ: Tilray shares still climbing in wake of its public Nasdaq debut

According to the company, total kilogram equivalents sold increased 745 kilograms to 1,514 kilograms, or 97%, compared to the prior year.

Average net selling price per gram increased from US$6.20 to US$6.38 (C$8.12 to C$8.36) for the three months ended June 30, 2017 and 2018, respectively. The company announced the increase was due to growth in higher potency product and extract sales.

Net loss for the quarter was US$12.8 million compared to US$2.4 million for the second quarter of 2017. the net loss also includes non-cash stock compensation charges of US$5.6 million compared to a US$35 thousand charged in the prior year period.

Adjusted EBITDA was a loss of $4.7 million compared to a loss of $1.9 million the second quarter last year.

The increased net loss and adjusted EBITDA decline was primarily due to the increase in operating expenses related to continued growth, expansion of international teams, and costs related to financing and the initial public offering (“IPO”).

Shares of Tilray were down 3.6% on Tuesday. 

Quick facts: Tilray Inc

Price: 10.26 USD

Market: NASDAQ
Market Cap: $1.28 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Sweet Earth Holdings goes public listing on the CSE under...

Sweet Earth Holdings (CSE: SE) CEO Peter Espig and CFO Chris Cooper joined Steve Darling from Proactive Vancouver to discuss the company that operates a large facility in Oregon which is the start of their process of going to seed to sale. Espig talks about all aspects of the company...

4 hours, 12 minutes ago

2 min read